Ticker brief
PODD INSULET CORP
Consumer, Non-cyclical · Healthcare-Products
last close
$164.48
1 day
+2.9%
14 days
+12.8%
mkt cap
$11.4B
signals 14d
20
authors 14d
10
Sentiment — last 14 days
daily mean sentiment, 2026-06-19 → 2026-07-02 · now -0.25 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @FluentInQuality | B | +0.96 | 8 | +0.56 |
| @VistaPResearch | C | · | 4 | +0.14 |
| @MacroAlphaHQ | A | +1.15 | 1 | -0.75 |
| @Minnvestor | A | -1.19 | 1 | +0.25 |
| @CEOStockWatcher | C | · | 1 | +0.25 |
| @BlueJay87476298 | B | +1.05 | 1 | +0.35 |
| @ClassicRoy | C | +2.01 | 1 | +0.25 |
| @VladBastion | B | +1.88 | 1 | +0.20 |
| @OracleNYSE | C | +0.49 | 1 | -0.40 |
| @PeloSwing | C | -1.44 | 1 | -0.40 |
Recent signals20of 20 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @PeloSwing | -0.40 | Reports FDA Class I recall for PODD Omnipods, despite stock reaction higher. | — | tweet ↗ |
| 2026-07-02 | @OracleNYSE | -0.40 | FDA updated PODD issue as Class I recall, the most serious type. | — | tweet ↗ |
| 2026-07-02 | @VistaPResearch | +0.05 | Article title pitches Modular Medical's pivot and easier diabetes care. | — | tweet ↗ |
| 2026-07-01 | @VladBastion | +0.20 | Detailed PODD thesis: recall hurt trust but guidance unchanged and quality score remains high. | +2.9% | tweet ↗ |
| 2026-06-30 | @VistaPResearch | +0.25 | Article title about Modular's Pivot and Insulet's Omnipod rewriting diabetes playbook. | +8.0% | tweet ↗ |
| 2026-06-30 | @ClassicRoy | +0.25 | Reports options volume surge multiples for top momentum names. | +8.0% | tweet ↗ |
| 2026-06-29 | @VistaPResearch | +0.25 | Article title about Modular's Pivot and Insulet's Omnipod rewriting diabetes playbook. | +4.3% | tweet ↗ |
| 2026-06-29 | @BlueJay87476298 | +0.35 | Goldman-style medtech note lists Buy ratings for ABT/BBNX/DXCM/PODD/MMED and Neutral TNDM. | +4.3% | tweet ↗ |
| 2026-06-29 | @CEOStockWatcher | +0.25 | Reply says PODD may be most interesting due to less exposure to regulation/reimbursement. | +4.3% | tweet ↗ |
| 2026-06-26 | @VistaPResearch | +0.00 | Modular Medical announces shipment of Pivot tubeless patch pumps. | +3.9% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.55 | Bullish on PODD pharmacy distribution, coverage and injection user switching. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.70 | Frames PODD as recurring-revenue machine growing 30% with $12B Type 2 market opening. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.35 | Describes PODD Omnipod tubeless patch that delivers insulin automatically. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.50 | Explains Omnipod consumable replacement model and lifelong pod demand. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.70 | Bullish on PODD Type 2 diabetes AID penetration and $12B+ market opportunity. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.55 | Describes PODD recurring revenue razor-and-blade model from disposable pods. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.55 | Lists PODD margins, operating margin expansion and free cash flow. | +10.5% | tweet ↗ |
| 2026-06-24 | @FluentInQuality | +0.60 | Says PODD achieved ten straight years of 20%+ revenue growth. | +10.5% | tweet ↗ |
| 2026-06-23 | @Minnvestor | +0.25 | Lists lowest forward PEG ratios among >3% gainers with >20% 3Y sales CAGR. | +14.3% | tweet ↗ |
| 2026-06-19 | @MacroAlphaHQ | -0.75 | Bearish on PODD despite Strong Buy and FDA-clearance headlines, framing PTs as exit liquidity. | +12.8% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.